Bausch Health Companies | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Amgen USD 11.97B 2.96B 2024-12
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bausch Health Companies USD 719M 124M 2024-09
Biogen USD 2.38B 675.8M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Danaher USD 2.08B 549M 2024-12
Drreddys Laboratories INR 1.1B 743M 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Prestige Brands USD 50.87M 666K 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Zoetis USD 1.98B 275M 2024-12



Bausch Health Companies Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.